[Crimean-Congo haemorrhagic fever: an enemy at the gates].
Crimea-Congo haemorrhagic fever is a tick-borne viral zoonosis with the potential of human-to-human transmission. The disease occurs in extensive areas in Asia, South-eastern Europe and Africa. Haemorrhagic manifestations constitute a prominent symptom of the late disease stage, with case fatality rates from 9 to 50%. The recent increase in the number of cases in Eastern Europe and the potential for nosocomial outbreaks indicate the advisability of diagnosis in every patient hospitalized in Italy with haemorrhagic fever.
Pittalis
Silvia
S
Dipartimento di Epidemiologia, Laboratorio di Virologia, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Rome, Italy.
Meschi
Silvia
S
Castilletti
Maria Concetta
MC
Di Caro
Antonino
A
Puro
Vicenzo
V
D000349:Africa / Q000453:epidemiology; D000820:Animal Diseases / Q000453:epidemiology; D000822:Animal Husbandry; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000453:epidemiology*; D018563:Disease Notification; D019353:Endemic Diseases; D005061:Europe, Eastern / Q000453:epidemiology; D003225:Hemorrhagic Fever Virus, Crimean-Congo / Q000276:immunology / Q000302:isolation & purification; D006479:Hemorrhagic Fever, Crimean / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007303:Insect Vectors / Q000821:virology; D007558:Italy / Q000453:epidemiology; D026863:Ixodidae / Q000821:virology; D009784:Occupational Diseases / Q000453:epidemiology; D010356:Patient Isolation; D012254:Ribavirin / Q000627:therapeutic use; D014765:Viral Vaccines; D015047:Zoonoses
D000998:Antiviral Agents; D014765:Viral Vaccines; D012254:Ribavirin